adjuvant nivolumab in resected oesophageal or goj cancer following chemo
Published 1 year ago • 138 plays • Length 9:10Download video MP4
Download video MP3
Similar videos
-
8:16
nivolumab for oesophageal cancer following chemoradiation therapy
-
2:13
adjuvant nivolumab as soc for high-risk muscle-invasive urothelial carcinoma after radical resection
-
3:13
attraction-3: nivolumab versus chemotherapy in advanced oesophageal squamous cell carcinoma
-
3:12
nivolumab for perioperative esophageal and gastroesophageal cancer: checkmate 577
-
4:14
adjuvant nivolumab in patients with resected esophageal or gej cancer (checkmate 577)
-
5:18
checkmate577: nivolumab in ec/gejc
-
2:47
attraction-4: nivolumab plus chemotherapy for gastric or gastroesophageal cancer
-
59:58
management of esophageal/gej cancers: an interdisciplinary tumor board on adjuvant immunotherapy
-
3:44
pembro plus chemo followed by resection and adjuvant pembro improves on soc for early nsclc
-
11:12
expert video report on immunotherapy in gastro oesophageal cancer from 2021 asco annual meeting
-
31:33
oesophageal cancer | neo-adjuvant chemotherapy | neo-adjuvant chemo-radiotherapy | cancer treatment
-
1:04:49
navigating multidisciplinary care with immunotherapy in esophageal/gej cancer
-
1:19
dr. kelly on the rationale for the checkmate-577 trial in esophageal/gej cancer
-
17:37
what is the most optimum perioperative treatment in esophageal cancer
-
13:47
checkmate 577 - is nivolumab adjuvant the standard of care in esophagus and gej?
-
3:08
adjuvant nivolumab after chemo-radiation for localized muscle-invasive bladder cancer
-
5:20
nivolumab vs chemotherapy for advanced esophageal squamous cell carcinoma
-
8:38
checkmate 459: nivolumab plus chemotherapy for gc / gejc / eac